Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA draft guidance on generic eye drug push Allergen shares lower
FDA draft guidance on generic eye drug push Allergen shares lower
FDA draft guidance on generic eye drug push Allergen shares lower
Submitted by
admin
on June 25, 2013 - 11:00am
Source:
Reuters
News Tags:
FDA
generics
Allergan
Restasis
Headline:
FDA draft guidance on generic eye drug push Allergen shares lower
Do Not Allow Advertisers to Use My Personal information
